Alimentiv is a London, Ontario-based CRO specializing in gastroenterology clinical trials. The company provides full-spectrum GI trial services and emphasizes expertise in protocol design, endoscopy scoring, histology, and advanced imaging modalities such as intestinal ultrasound and magnetic resonance enterography. Alimentiv also highlights its role in developing centralized endoscopy in IBD, the UC-100 Score, the Robarts Histopathology Index, and SIQ-UC/SIQ-CD patient-reported outcomes.